microRNAs and Integrative Control on Cardiopoiesis - CHANGE OF GRANTEE INSTITUTIO

microRNA 和心脏生成的综合控制 - 受资助机构变更

• 批准号: 8915242
• 负责人: MARK MERCOLA
• 金额: $ 40.54万
• 依托单位: UNIVERSITY OF CALIFORNIA, SAN DIEGO
• 依托单位国家: 美国
• 财政年份: 2014
• 资助国家: 美国
• 起止时间: 2014-02-05 至 2016-03-31
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/8915242
• 关键词: Address; Adult; Arizona; Biological; Biological Assay; Biological Process; Biology; Boxing; Cardiac; Cardiac Myocytes; Cardiology; Cardiovascular system; Cell Differentiation process; Cell physiology; Cells; Cellular Assay; Clinical; Collection; Data; Databases; Development; Disease; Drug Targeting; Embryo; Embryonic Heart; Endoderm; Endothelial Cells; Fibroblasts; Genome; Genomic Library; Heart; Heart Diseases; Individual; Knock-out; Knowledge; Lead; Left; Libraries; Logic; Mammals; Mesoderm; MicroRNAs; Modeling; Molecular Profiling; Mus; Natural regeneration; Network-based; Oligonucleotides; Outcome; Physiology; Play; Preclinical Drug Evaluation; Prevalence; Primitive foregut structure; Process; Proteins; Proteome; Proteomics; Research; Role; Signal Pathway; Signal Transduction; Signaling Protein; Small Interfering RNA; Smooth Muscle; Smooth Muscle Myocytes; Stem cells; System; Systems Analysis; Technology; Testing; Therapeutic; Validation; Vascular Endothelial Cell; Vascular Smooth Muscle; Xenopus; arm; base; cardiac regeneration; cardiogenesis; cell type; follow-up; gain of function; heart cell; heart function; high throughput technology; in vivo; inhibitor/antagonist; innovation; insight; loss of function; model building; network models; novel; progenitor; protein protein interaction; research study; screening; small molecule; stem; stem cell differentiation

DESCRIPTION (provided by applicant): microRNAs (miRs) naturally fine-tune the responsiveness of signaling pathways, and a number of miRs are known to play important roles in heart development and disease. To date, knowledge of miRs involved in any biological process comes primarily from expression profiling. Relatively few miRs have been tested for actual regulatory roles, therefore our current knowledge of both the prevalence, importance and actual function of miRs in biological control remains rudimentary. Our data show that it is feasible to apply high throughput technology to screen stem and progenitor cell-based assays against whole genome libraries of miR oligonucleotide mimics. Using this approach, we discovered miRs that play unanticipated roles in initiating embryonic heart formation and act by distinguishing cardiac mesoderm from foregut endoderm. Here we propose to apply this same approach to identify miRs that control the next step in cardiogenesis: the differentiation and diversification cardiomyocytes, smooth muscle, and vascular endothelial cells from a common progenitor. Although the proper diversification of cardiopoietic lineages is critical to heart formation, regeneration and disease, little is known about how the process is controlled. To address this question, we will apply whole genome miR library screening, followed by an iterative process of validation of individual miRs and targets and model building to yield a refined network of signaling proteins and miRs that control cardiopoiesis. The network of miRs and target proteins will be evaluated through targeted gain and loss of function studies in embryos to visualize how miRs regulate signaling proteins in order to guide cardiopoiesis. This research will yield two outcomes: First, the functional screening and subsequent in vivo testing will reveal miRs that control cardiopoiesis and hence be important for development, disease and regeneration. Second, we will construct and test signaling networks composed of the miR targets that will offer insight into the systems-level control of cardiopoiesis. The research is innovative in that it merges state of the art functional screening of miRs with miR target identification and systems analysis in order to expose the logic underying the emergence of distinct cell types in the heart from stem cells.

描述（由申请人提供）：微小RNA（miR）天然微调信号通路的响应性，已知许多miR在心脏发育和疾病中发挥重要作用。迄今为止，miR参与任何生物过程的知识主要来自表达谱分析。相对较少的miR已被测试的实际监管作用，因此，我们目前的知识的流行，重要性和实际功能的miR在生物控制仍然是基本的。我们的数据表明，这是可行的，应用高通量技术筛选干细胞和祖细胞为基础的测定对全基因组文库的miR寡核苷酸模拟物。使用这种方法，我们发现miR在启动胚胎心脏形成中发挥意想不到的作用，并通过区分心脏中胚层和前肠内胚层发挥作用。在这里，我们建议应用这种相同的方法来识别控制心脏发生下一步的miR：从共同的祖细胞分化和多样化心肌细胞，平滑肌和血管内皮细胞。虽然心脏生成谱系的适当多样化对心脏形成，再生和疾病至关重要，但对该过程如何控制知之甚少。为了解决这个问题，我们将应用全基因组miR文库筛选，然后进行单个miR和靶标的验证和模型构建的迭代过程，以产生控制心脏生成的信号蛋白和miR的精细网络。miR和靶蛋白的网络将通过在胚胎中的靶向功能获得和丧失研究来评估，以可视化miR如何调节信号蛋白以指导心脏生成。这项研究将产生两个结果：首先，功能筛选和随后的体内测试将揭示控制心脏生成的miR，因此对发育，疾病和再生很重要。其次，我们将构建和测试由miR靶点组成的信号网络，这将为心脏发生的系统水平控制提供深入了解。这项研究的创新之处在于，它将最先进的miR功能筛选与miR靶点鉴定和系统分析相结合，以揭示心脏中不同细胞类型从干细胞中出现的逻辑。